ScholarIQanswers from OpenAlex

Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor

PaperCitations, authors & open-access status

Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor have?

ScholarIQcitation count

Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor has 26 citations in the OpenAlex counts ScholarIQ stores.

When was Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor published?

ScholarIQyear

Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor has 2016 year in the ScholarIQ index.

What is the open-access status of Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor?

ScholarIQoa status

Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor has closed oa status in the ScholarIQ index.

What is the DOI of Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor?

ScholarIQdoi

The DOI for Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor is on the source record.

What is the PMID of Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor?

ScholarIQpmid

The PMID for Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor is on the source record.

What is the OpenAlex record for Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor?

ScholarIQopenalex

The OpenAlex for Novel strategy for cystitis glandularis: Oral treatment with cyclooxygenase‐2 inhibitor is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial